Grade My Investments
HomeFree Stock Grades › BLFS

BioLife Solutions, Inc. (BLFS) Stock Grade

BLFS · Healthcare

A+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$1.2B
P/E Ratio
Revenue Growth (YoY)
+17.0%
Net Margin
-12.6%
Return on Equity
Dividend Yield
None

About BioLife Solutions, Inc.'s fundamentals

BioLife Solutions is a $1.2 billion healthcare company in the medical instruments and supplies sector experiencing strong revenue growth of 17.0% year-over-year. However, the company currently operates at a net loss with a negative net margin of -12.6%, and reported a net loss in its latest annual statement. Despite the accounting losses, the company maintains positive free cash flow, indicating it is generating cash from operations even while unprofitable. The company does not pay a dividend.

Track BLFS free — no credit card required. Live grade + monthly AI report →